NCT02005107

Venlafaxine PK Following Bariatric Surgery

A Comparison of Immediate and Extended Release Venlafaxine Following Bariatric Surgery

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 12 (actual)
• Sponsor: North Dakota State University · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

This study is being conducted to evaluate how the body absorbs and processes the immediate release (IR) and sustained release (XR) medication venlafaxine (Effexor®). Subject who are 1-3 years post gastric bypass or sleeve gastrectomy surgery will be invited to participate. Non-surgical controls will also be enrolled based on a matching criteria to post gastric bypass subjects. Participants will be asked to complete two 12-hour study days approximately 11 days apart. This study will enroll up to 30 participants.

Conditions

• Roux en Y Gastric Bypass
• Sleeve Gastrectomy

Interventions

Type	Name	Description
DRUG	Venlafaxine IR and Venlafaxine XR

Timeline

• Start date: 2013-12-01
• Primary completion: 2015-03-01
• Completion: 2015-03-01
• First posted: 2013-12-09
• Last updated: 2016-04-06

Locations

1 site across 1 country: United States